BCTXW (BriaCell Therapeutics) Total Liabilities: $3.66 Mil (As of Apr. 2026)


BCTXW BriaCell Therapeutics Corp BCTXW
23 GF Score
Price $0.00
! 2 Warning Signs
View Full Analysis

What is BriaCell Therapeutics Total Liabilities?

BriaCell Therapeutics BCTXW 23 Total Liabilities is $3.66 Mil as of Apr. 2026. GuruFocus rates BCTXW with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

BriaCell Therapeutics's Total Liabilities for the quarter that ended in Apr. 2026 was $3.66 Mil.

BriaCell Therapeutics's quarterly Total Liabilities declined from Oct. 2025 ($3.73 Mil) to Jan. 2026 ($3.38 Mil) but then increased from Jan. 2026 ($3.38 Mil) to Apr. 2026 ($3.66 Mil).

BriaCell Therapeutics's annual Total Liabilities declined from Jul. 2023 ($30.94 Mil) to Jul. 2024 ($8.56 Mil) and declined from Jul. 2024 ($8.56 Mil) to Jul. 2025 ($4.32 Mil).

BriaCell Therapeutics Total Liabilities Historical Data

* Premium members only.

The historical data trend for BriaCell Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BriaCell Therapeutics Total Liabilities Chart

BriaCell Therapeutics Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.37 32.25 30.94 8.56 4.32

BriaCell Therapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.06 4.32 3.73 3.38 3.66
BCTXW
23GF Score
BriaCell Therapeutics Corp BCTXW
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BriaCell Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BriaCell Therapeutics's Total Liabilities for the fiscal year that ended in Jul. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.978+(0+0.338
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=4.32

Total Liabilities=Total Assets (A: Jul. 2025 )-Total Equity (A: Jul. 2025 )
=21.65-17.334
=4.32

BriaCell Therapeutics's Total Liabilities for the quarter that ended in Apr. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.59+(0+0.072
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=3.66

Total Liabilities=Total Assets (Q: Apr. 2026 )-Total Equity (Q: Apr. 2026 )
=27.071-23.409
=3.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $3.66 Mil mean?
BriaCell Therapeutics (BCTXW) has a Total Liabilities of $3.66 Mil as of Apr. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for BriaCell Therapeutics and its competitors.
Is BriaCell Therapeutics' Total Liabilities too high?
BriaCell Therapeutics' current Total Liabilities is $3.66 Mil. Overall, BriaCell Therapeutics has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does BriaCell Therapeutics' Total Liabilities compare to VRTX and REGN?
BriaCell Therapeutics' Total Liabilities of $3.66 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for BriaCell Therapeutics and its competitors. BriaCell Therapeutics's current Total Liabilities is $3.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BriaCell Therapeutics stock overvalued right now?
BriaCell Therapeutics (BCTXW) has a current Total Liabilities of $3.66 Mil. The current Total Liabilities is $3.66 Mil. BriaCell Therapeutics' overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For BriaCell Therapeutics (BCTXW), the current Total Liabilities is $3.66 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BriaCell Therapeutics Business Description

Address 235-15th Street, Suite 300, 3rd Floor, Bellevue Centre, West Vancouver, Vancouver, BC, CAN, V7T 2X1
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
23GF Score

Get the complete analysis for BCTXW

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price